Navigation Links
Pharmasset Reports Fiscal Year End 2008 Financial Results
Date:12/11/2008

by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, has completed a 4-week clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial. Pharmasset also anticipates filing an IND for its second generation nucleotide inhibitor for HCV, PSI-7851 in the first quarter of 2009. Pegasys(R) and Copegus(R) are registered trademarks of Roche.

    Contact
    Richard E. T. Smith, Ph.D.
    VP, Investor Relations and Corporate Communications
    richard.smith@pharmasset.com
    Office: +1 (609) 613-4181

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 fi
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
2. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
3. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
4. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
5. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
6. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
7. Pharmasset Receives Notice of Allowance
8. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014   Unique Pizza and Subs ... Pink: UPZS), a Delaware Corporation, is pleased to ... Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that ... agreement, US-based Larasan will work with Unique to ... through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... N.Y. and PARIS , ... REGN ) and Sanofi (EURONEXT: SAN and NYSE: ... Phase 3 ODYSSEY trials of alirocumab in people with ... percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) ...  Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... N.C., Aug. 12, 2011 Although medical devices ... complexities require medical device companies to invest more ... generic pharmaceutical products.   Tactical marketers ... activities, such as troubleshooting post-launch and managing product ...
... Misonix, Inc. (NASDAQ: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... other surgical and medical applications, has entered into ... Solutions Australasia Pty. Ltd., based in Newport, Victoria, ...
Cached Medicine Technology:Medical Device Marketing Groups Focus More Resources on Tactical Activities When Compared to Pharmaceutical Counterparts 2Misonix Announces New Distribution Agreement for Australia and New Zealand 2Misonix Announces New Distribution Agreement for Australia and New Zealand 3
(Date:7/30/2014)... July 30, 2014 The American ... U.S. Sens. Thad Cochran (R-MS) and Roger Wicker ... in telemedicine coverage under Medicare, Medicaid and Federal ... both Mississippi Republicans, introduced the Telehealth Enhancement Act ... House version, H.R. 3306, introduced by Rep. Gregg ...
(Date:7/30/2014)... Portland, OR (PRWEB) July 30, 2014 ... and evaluating the quality of care that their ... company’s CEO, Mr. Andrew Rowe, discussed the importance ... order to improve physician performance and quality of ... for effective practitioner evaluation, Mr. Rowe elaborated on ...
(Date:7/30/2014)... Aquarium Research Institute (MBARI) have observed a deep-sea octopus ... than any other known animal. Throughout this time, the ... predators. This amazing feat represents an evolutionary balancing act ... plenty of time to develop within their eggs, and ... or no food. , Every few months for the ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent of ... nasty condition which occurs most frequently in people between the ... two and half years if not treated. , Adhesive capsulitis ... reason: it can render your shoulder so stiff, it's almost ... aren't in too much pain to get dressed in the ...
(Date:7/30/2014)... 2014 (HealthDay News) -- For patients with asthma, just ... trigger airway inflammation for at least 24 hours, a ... smell, but also what you think you smell," study ... Center in Philadelphia, said in a Monell news release. ... fragrances. When we expect that an odor is harmful, ...
Breaking Medicine News(10 mins):Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2
... A53A iceberg located just east of the South Georgia ... Ocean. , A huge fissure was spotted running south ... C-CORE, the Canadian ice-tracking service, while studying satellite images ... using the Polar View monitoring programme. , The radar ...
... study finds , , FRIDAY, March 14 (HealthDay News) -- Higher ... harm older men, U.S. research shows. , A ... followed 1,000 seniors in three Florida retirement communities for up ... levels of anxiety at the start of the study lived ...
... and Meet with Elected,Officials, WASHINGTON, March 14 ... D.C., this April 1 to meet with,congressional leaders and ... Act, support for epilepsy public health,programs and more research ... one of 50 young people with epilepsy participating in,Kids ...
... to Visit Washington, D.C., and Meet with Elected,Officials, ... will travel to Washington, D.C., this April 1 to ... of the,Americans with Disabilities Act, support for epilepsy public ... Foster, 16, is one of 50 young people ...
... Management,Services, Inc. (Nasdaq: BDMS ), operators of ... The Company,s board of directors,has declared a quarterly ... common,stock. The dividend is payable April 11, 2008, ... Dental Management Services, Inc. acquires, develops, and manages,geographically ...
... weight rapidly after having their tonsils and adenoids removed ... short-term, but over time they may relapse or even ... new research from Cincinnati Childrens Hospital Medical Center. ... children, ranging from about 19 per 10,000 in Canada ...
Cached Medicine News:Health News:Anxiety Helps Elderly Women Live Longer 2Health News:Colorado Youth Named National Epilepsy Spokesperson 2Health News:Virginia Youth Named National Epilepsy Spokesperson 2Health News:The ABCs of childhood z's: Snoring may be chronic despite surgery 2
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... modification of the Farnsworth-Munsell 100 Hue Test. It ... the in-depth study of a color vision defect. ... ease or difficulty in distinguishing color differences in ... 15 color reference caps with Munsell notations, plus ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
... HRR 4th edition pseudoisochromatic test from Richmond Products ... plates and the 14 diagnostic series for a ... has its own tab for easy and clean ... of instructions in English and a laminated copy ...
Medicine Products: